Javascript is not activated in your browser. This website needs javascript activated to work properly.
You are here

Chromosome aberrations in prophylactic mastectomies from women belonging to breast cancer families

  • C Petersson
  • N Pandis
  • F Mertens
  • A Adeyinka
  • C Ingvar
  • A Ringberg
  • I Idvall
  • L Bondeson
  • A Borg
  • Håkan Olsson
  • U Kristoffersson
  • F Mitelman
Publishing year: 1996-07
Language: English
Pages: 185-188
Publication/Series: Genes, Chromosomes and Cancer
Volume: 16
Issue: 3
Document type: Journal article
Publisher: John Wiley & Sons

Abstract english

Short-term cultures of samples from eight prophylactic mastectomies from five unrelated women who were genetically predisposed to breast cancer were analyzed cytogenetically. Clonal chromosome abnormalities were detected in five breasts. Three samples from two women had aberrations involving the short arm of chromosome 3, with a breakpoint in 3p14 in common. Three samples from three women had rearrangements of 1q. Two of them, one of which also displayed a 3p14 rearrangement, shared a breakpoint in 1q41. Both 1q41 and, in particular, 3p14 have been reported to be rearranged frequently in malignant breast proliferations. Whether alterations of genes in these bands are essential in mammary tumorigenesis and, if so, whether they are equally important in sporadic and in hereditary cases remains to be explored.


  • Cancer and Oncology
  • Medical Genetics
  • Adult
  • Breast Neoplasms
  • Cells, Cultured
  • Chromosome Aberrations
  • Female
  • Genetic Diseases, Inborn
  • Humans
  • Hyperplasia
  • Karyotyping
  • Mastectomy
  • Middle Aged
  • Precancerous Conditions
  • Risk Factors
  • Case Reports
  • Journal Article
  • Research Support, Non-U.S. Gov't


  • Lund Melanoma Study Group
  • Surgery Research
  • Pathology, Malmö
  • ISSN: 1045-2257
Åke Borg
Åke Borg
E-mail: ake [dot] borg [at] med [dot] lu [dot] se

Principal investigator

Oncology and Pathology, MV

+46 46 275 25 52

MV 404 C21B2


Project manager

Familial Breast Cancer



Oncology and Pathology, MV

MV 404 C21C2